Arbutus Biopharma Corp
ABUS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001447028
No open-market purchases or sales by Arbutus Biopharma Corp insiders were filed in the last 90 days; 176 institutions reported holding it in 13F filings for Q2 2026, worth $674.9M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Arbutus Biopharma Corp as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 119
- −3 vs. Q4 2021
- Shares held
- 43.9M
- +4.20M (+10.6%) vs. Q4 2021
- Total value
- $130.6M
- −$23.8M (−15.4%) vs. Q4 2021
- New holders
- 17
- 40 more added
- Sold out
- 20
- 35 more reduced
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ABUS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 176 | $674.9M |
| Q1 2026 | 167 | $625.4M |
| Q4 2025 | 172 | $586.9M |
| Q3 2025 | 166 | $536.4M |
| Q2 2025 | 163 | $365.0M |
| Q1 2025 | 168 | $390.1M |
| Q4 2024 | 154 | $340.3M |
| Q3 2024 | 144 | $389.2M |
| Q2 2024 | 131 | $298.4M |
| Q1 2024 | 119 | $215.2M |
| Q4 2023 | 112 | $197.4M |
| Q3 2023 | 99 | $143.8M |
| Q2 2023 | 111 | $152.4M |
| Q1 2023 | 122 | $189.3M |
| Q4 2022 | 114 | $126.3M |
| Q3 2022 | 127 | $89.1M |
| Q2 2022 | 113 | $120.0M |
| Q1 2022 | 119 | $130.6M |
| Q4 2021 | 123 | $154.4M |
| Q3 2021 | 100 | $149.8M |
| Q2 2021 | 91 | $87.6M |
| Q1 2021 | 94 | $86.5M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Arbutus Biopharma Corp; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Susquehanna International Group, LLP | 440,665 | $1.31M | 0.00% | −76,250−14.8% | Reduced |
| Prudential Financial Inc | 456,660 | $1.36M | 0.00% | +51,300+12.7% | Added |
| Primecap Management Co | 461,000 | $1.37M | 0.00% | −9,000−1.9% | Reduced |
| Boothbay Fund Management, LLC | 490,623 | $1.46M | 0.05% | +31,981+7.0% | Added |
| Wellington Management Group LLP | 505,264 | $1.51M | 0.00% | +225,175+80.4% | Added |
| Northern Trust Corp | 774,239 | $2.31M | 0.00% | +39,771+5.4% | Added |
| Advisor Group Holdings, Inc. | 1,364,524 | $4.07M | 0.01% | −3700.0% | Reduced |
| Goldman Sachs Group Inc | 1,541,185 | $4.59M | 0.00% | +847,914+122.3% | Added |
| FourWorld Capital Management LLC | 1,547,739 | $4.61M | 2.86% | +1,547,739 | New |
| Nuveen Asset Management, LLC | 1,605,514 | $4.62M | 0.00% | −406,295−20.2% | Reduced |
| Geode Capital Management, LLC | 1,729,978 | $5.16M | 0.00% | +60,354+3.6% | Added |
| State Street Corp | 1,774,936 | $5.29M | 0.00% | +91,107+5.4% | Added |
| Millennium Management LLC | 2,016,324 | $6.01M | 0.01% | −1,022,861−33.7% | Reduced |
| Assenagon Asset Management S.A. | 2,121,406 | $6.32M | 0.02% | +2,034,737+2,347.7% | Added |
| Two Seas Capital LP | 2,199,069 | $6.55M | 5.49% | +1,373,500+166.4% | Added |
| Brookfield Asset Management Inc. | 2,328,054 | $6.94M | 0.03% | +1,135,165+95.2% | Added |
| Hudson Bay Capital Management LP | 4,483,327 | $13.4M | 0.19% | +2,677,627+148.3% | Added |
| Vanguard Group Inc | 4,738,178 | $14.1M | 0.00% | +182,684+4.0% | Added |
| BlackRock Inc. | 6,824,829 | $20.3M | 0.00% | +658,480+10.7% | Added |
| RTW Investments, LP | 0 | $0 | 0.00% | −2,504,493−100.0% | Sold out |
| Great Point Partners LLC | 0 | $0 | 0.00% | −668,907−100.0% | Sold out |
| Quinn Opportunity Partners LLC | 0 | $0 | 0.00% | −276,485−100.0% | Sold out |
| PointState Capital LP | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −172,229−100.0% | Sold out |
| First Quadrant L P | 0 | $0 | 0.00% | −75,700−100.0% | Sold out |
| Pitti Group Wealth Management, LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −48,743−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −40,014−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −12,500−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −17,579−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −11,271−100.0% | Sold out |
| Traynor Capital Management, Inc. | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| QCM Cayman, Ltd. | 0 | $0 | 0.00% | −10,205−100.0% | Sold out |
| Secure Asset Management, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Bank Julius Baer & Co. Ltd, Zurich | 0 | $0 | 0.00% | −7,800−100.0% | Sold out |
| TD Waterhouse Canada Inc. | 0 | $0 | 0.00% | −900−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −475−100.0% | Sold out |
| Masso Torrence Wealth Management Inc. | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Reilly Financial Advisors, LLC | – | – | – | – | Not filed |